Your browser doesn't support javascript.
loading
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Steiner, Sophie; Schwarz, Tatjana; Corman, Victor M; Gebert, Laura; Kleinschmidt, Malte C; Wald, Alexandra; Gläser, Sven; Kruse, Jan M; Zickler, Daniel; Peric, Alexander; Meisel, Christian; Meyer, Tim; Staudacher, Olga L; Wittke, Kirsten; Kedor, Claudia; Bauer, Sandra; Besher, Nabeel Al; Kalus, Ulrich; Pruß, Axel; Drosten, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen; Hanitsch, Leif G.
Afiliación
  • Steiner S; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Schwarz T; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research, Associated Partner, Charitéplatz 1, Berlin, Germany.
  • Corman VM; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Gebert L; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research, Associated Partner, Charitéplatz 1, Berlin, Germany.
  • Kleinschmidt MC; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Wald A; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Gläser S; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kruse JM; Department of Pulmonary Medicine, University Hospital Leipzig, Leipzig, Germany.
  • Zickler D; Department of Pulmonary Medicine and Infectious Diseases, Vivantes-Klinikum Neukölln, Berlin, Germany.
  • Peric A; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Meisel C; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Meyer T; Department of Pulmonary Medicine and Infectious Diseases, Vivantes-Klinikum Friedrichshain, Berlin, Germany.
  • Staudacher OL; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Wittke K; Department of Immunology, Labor Berlin GmbH, Berlin, Germany.
  • Kedor C; Department of Immunology, Labor Berlin GmbH, Berlin, Germany.
  • Bauer S; Department of Immunology, Labor Berlin GmbH, Berlin, Germany.
  • Besher NA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kalus U; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Pruß A; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Drosten C; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Augustenburger Platz 1 and Berlin Institute of Health, Berlin, Germany.
  • Volk HD; Institute of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Scheibenbogen C; Institute of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Hanitsch LG; Institute of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Front Immunol ; 13: 840126, 2022.
Article en En | MEDLINE | ID: mdl-35359967
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza